v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Loss for the period $ (118,786,726) $ (7,725,194)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation 644,059 349,035
Share based compensation 1,878,363 3,387,475
Change in fair value of derivative liabilities 105,317,692
Unrealized foreign currency transaction (gain) loss 85,088 629,163
Amortization 2,174 801
Changes in operating assets and liabilities:    
Accounts receivable 270,824
Other payables 1,890,795 (241,801)
Lease liability (212,283) (131,790)
Prepaid expenses and other assets (102,350) (189,219)
Net cash used in operating activities (9,283,188) (3,650,706)
Cash flows from investing activities    
Purchase of property, equipment including construction in progress (5,521,276) (297,706)
Purchase of intangible assets and trademarks
Net cash used in investing activities (5,521,276) (297,706)
Cash flows from financing activities    
Proceeds from issuance of SAFE notes 2,500,000
Proceeds from exercise of warrants 27,186,518
Proceeds from merger and PIPE transaction, net of transaction costs 98,167,633
Net cash provided by financing activities 127,854,151
Effect of exchange rate changes on cash (18,186) (194,118)
Net increase (decrease) in cash and cash equivalents 113,031,501 (4,142,530)
Cash and cash equivalents at beginning of period 222,939 4,848,855
Cash and cash equivalents at end of period 113,254,440 706,325
Supplemental disclosures of non-cash transactions:    
Initial recognition of warrant liabilities at close of the business combination 20,526,410
Initial recognition of net assets at close of the business combination 2,458,713
Conversion of SAFE liabilities into equity at close of the business combination 11,183,077
Issuance of shares to a service provider 269,000
Reclassification of warrant liabilities to equity upon exercise $ 46,789,330